Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Predictus BioSciences
AddedFeb 19, 2024
UpdatedJun 18, 2026
Predictus BioSciences

Predictus BioSciences

Closed

Predictus BioSciences, a life science company based in Massachusetts, specializes in drug discovery services.

HQ
Massachusetts, US
Founded
2010
Overview
Compare
Fundraising
Employees
Website

Predictus BioSciences, founded in 2010 and based in Massachusetts, is a life science company specializing in drug discovery services. The company's core mission is to revolutionize cancer treatment by developing biomarkers that predict chemotherapy outcomes, thereby enhancing personalized medicine. Predictus BioSciences focuses on leveraging cutting-edge research to address unmet needs in oncology, aiming to improve treatment efficacy and patient quality of life.

Notable affiliated individuals include leading scientists and researchers in the field of oncology and drug discovery. Predictus BioSciences has garnered attention for its innovative approach to personalized cancer treatment, contributing significantly to advancements in predictive biomarkers. The company's impactful research has the potential to transform chemotherapy protocols, offering more tailored and effective treatment options for cancer patients globally.

Predictus BioSciences - Similar Companies

Pbs-Bio logo

Pbs-Bio

Predictive Biosciences logo

Predictive Biosciences

Empiri logo

Empiri

empiricancer.com

Predictive Oncology logo

Predictive Oncology

Stemina Biomarker Discovery logo

Stemina Biomarker Discovery

stemina.com

PredxBio logo

PredxBio

predxbio.com

Perscitus Biosciences logo

Perscitus Biosciences

Episteme Prognostics logo

Episteme Prognostics

epistemedx.com

Predictiv logo

Predictiv

predictivcare.com

Path BioAnalytics logo

Path BioAnalytics

Precede Biosciences logo

Precede Biosciences

precede.bio

BioAI Health logo

BioAI Health

bioaihealth.com

Noble Life Sciences logo

Noble Life Sciences

noblelifesci.com

Previse logo

Previse

previsedx.com

Predictive Health Diagnostics Company logo

Predictive Health Diagnostics Company

Predictus BioSciences - Quick Facts

Who are Predictus BioSciences' competitors?

Companies similar to Predictus BioSciences include Pbs-Bio, Predictive Biosciences, Empiri and Predictive Oncology.

When was Predictus BioSciences founded?

Predictus BioSciences was founded in 2010.

Where is Predictus BioSciences' headquarters located?

Predictus BioSciences' headquarters is located in Massachusetts, US.

How much has Predictus BioSciences raised to-date?

As of Jan 1, 2019, Predictus BioSciences has raised a total of $500k (USD).

Predictus BioSciences - Classification

Industry
  • Professional Service Companies
Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Customer
  • Enterprise
Main Product
  • Drug Discovery
Tags
  • Biotech
  • Consulting
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 5 more industry codes
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified